“Baseline Antimullerian Hormone Level Does Not Serve As a Predictor of Uterine Fibroid Treatment Outcomes”. The Journal of Reproductive Medicine, vol. 68, no. 1, July 2025, pp. 576-90, https://www.thereproductivemedicine.com/Home/article/view/176.